The sales are small in absolute and relative terms and consistent with routine portfolio management. No cause for concern unless followed by larger sales or negative fundamentals. Monitor upcoming earnings and cash flow trends.
Price Chart
Executive Summary
Two TransMedics insiders conducted open-market share sales within the past week, totaling approximately $299,000 in proceeds. Stephanie Lovell sold $178,500 worth of shares, and Anil Ranganath sold $120,200. David Weill exercised options but did not sell shares outright — his transaction was a derivative exercise with tax withholding likely to follow separately.
Key Financial Metrics
Key Facts
- Stephanie Lovell sold 1,193 shares at $149.62, totaling $178,497 in open-market proceeds.
- Anil P. Ranganath sold 864 shares at $139.12, totaling $120,200 in open-market proceeds.
- David Weill exercised 3,571 derivative securities at $14.20 — this is not a sale but an option exercise; no open-market selling occurred in this transaction.
- Total open-market proceeds from selling insiders: $298,697.
- Total value represents ~0.006% of TransMedics' $4.8B market cap — well below materiality threshold.
Financial Impact
$298.7K in open-market share sales by two insiders; no net cash inflow to company. Derivative exercise by Weill is non-cash and does not reflect sentiment.
Risk Factors
- Perception risk if media or retail investors misinterpret derivative exercises as selling pressure.
- Potential for increased scrutiny if future sales accelerate.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CONTEXT: Insider Cluster Data (3 trades, 7d window) | cluster-TMDX-1772838805586 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Jun 12, 2026 16w ago | Institutional Cluster | $72.91 $88.27 | ▲ +21.07% | ▲ +17.80% | $78.63 (+7.85%) |
Jun 11, 2026 16w ago | Institutional Cluster | $73.59 $89.98 | ▲ +22.27% | ▲ +17.88% | $78.63 (+6.85%) |
Apr 10, 2026 25w ago | DEFA14A | $114.00 $71.12 | ▼ −37.62% | ▼ −47.95% | $78.63 (−31.03%) |
Mar 2, 2026 30w ago | Insider Cluster | $147.00 $70.46 | ▼ −52.07% | ▼ −61.39% | $78.63 (−46.51%) |
Feb 27, 2026 31w ago | 8-K | $145.26 $70.46 | ▼ −51.49% | ▼ −60.88% | $78.63 (−45.87%) |
Feb 24, 2026 31w ago | 8-K | $131.85 $68.00 | ▼ −48.43% | ▼ −55.38% | $78.63 (−40.36%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access